|
nalidixic acid |
|
CHEBI:100147 |
|
A monocarboxylic acid comprising 1,8-naphthyridin-4-one substituted by carboxylic acid, ethyl and methyl groups at positions 3, 1, and 7, respectively. An orally administered antibacterial, it is used in the treatment of lower urinary-tract infections due to Gram-negative bacteria, including the majority of E. coli, Enterobacter, Klebsiella, and Proteus species. |
|
 
This entity has been manually annotated by the ChEBI Team.
|
|
CHEBI:7456
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14/h4-6H,3H2,1-2H3,(H,16,17) |
MHWLWQUZZRMNGJ-UHFFFAOYSA-N |
CCn1cc(C(O)=O)c(=O)c2ccc(C)nc12 |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
(via quinolone antibiotic )
(via heterocyclic antibiotic )
DNA synthesis inhibitor
Any substance that inhibits the synthesis of DNA.
antibacterial drug
A drug used to treat or prevent bacterial infections.
|
|
antibacterial drug
A drug used to treat or prevent bacterial infections.
|
|
View more via ChEBI Ontology
1-ethyl-7-methyl-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
|
acide nalidixique
|
ChemIDplus
|
acido nalidixico
|
ChemIDplus
|
acidum nalidixicum
|
ChemIDplus
|
nalidixic acid
|
ChemIDplus
|
1,4-dihydro-1-ethyl-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid
|
ChemIDplus
|
1-Aethyl-7-methyl-1,8-naphthyridin-4-on-3-karbonsaeure
|
ChemIDplus
|
1-ethyl-1,4-dihydro-7-methyl-4-oxo-1,8-naphthyridine-3-carboxylic acid
|
ChemIDplus
|
1-ethyl-7-methyl-1,4-dihydro-1,8-naphthyridin-4-one-3-carboxylic acid
|
ChemIDplus
|
1-Ethyl-7-methyl-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid
|
ChEMBL
|
3-carboxy-1-ethyl-7-methyl-1,8-naphthyridin-4-one
|
ChemIDplus
|
Nalidixic acid
|
KEGG COMPOUND
|
NALIDIXIC ACID
|
ChEMBL
|
1875
|
DrugCentral
|
1880
|
VSDB
|
BE612258
|
Patent
|
C05079
|
KEGG COMPOUND
|
D00183
|
KEGG DRUG
|
DB00779
|
DrugBank
|
LSM-5590
|
LINCS
|
Nalidixic_Acid
|
Wikipedia
|
NIX
|
PDBeChem
|
US3590036
|
Patent
|
View more database links |
389-08-2
|
CAS Registry Number
|
KEGG COMPOUND
|
389-08-2
|
CAS Registry Number
|
ChemIDplus
|
750515
|
Reaxys Registry Number
|
Reaxys
|
11321869
|
PubMed citation
|
Europe PMC
|
12002106
|
PubMed citation
|
Europe PMC
|
12399485
|
PubMed citation
|
Europe PMC
|
12702698
|
PubMed citation
|
Europe PMC
|
14107587
|
PubMed citation
|
Europe PMC
|
16107187
|
PubMed citation
|
Europe PMC
|
16423473
|
PubMed citation
|
Europe PMC
|
16667857
|
PubMed citation
|
Europe PMC
|
16803589
|
PubMed citation
|
Europe PMC
|
17132068
|
PubMed citation
|
Europe PMC
|
17631104
|
PubMed citation
|
Europe PMC
|
18788798
|
PubMed citation
|
Europe PMC
|
19071706
|
PubMed citation
|
Europe PMC
|
28166217
|
PubMed citation
|
Europe PMC
|
|